Search
for
Sort by
Research 361–390 of 1000+
- Women with alopecia exhibit a higher risk for thyroid cancer: A nationwide cohort study
- The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Afro-Ethnic Hairstyling Trends, Risks, and Recommendations
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Associations of dietary indices with risk of all-cause and cardiovascular mortality in hypertensive adults
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- Preparatory work to support the risk assessment for peri‐ and postmenopausal women taking food supplements containing isolated isoflavones
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- 50835 Air Quality Index (AQI) and atopic dermatitis risk in Taiwan: A nationwide population-based cohort study
- Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?
- A REVIEW ON COLOURFUL MEHENDI: THE RISK OF PARAPHENYLENEDIAMINE
- Sensitization and Clinically Relevant Allergy to Hair Dyes and Clothes from Black Henna Tattoos: Do People Know the Risk? An Uncommon Serious Case and a Review of the Literature
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- Finasteride. dutasteride risk of suicide and sexual dysfunction
- Anabolic androgenic steroids impact on cardiovascular risk and cardiovascular events. The literature review
- Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
- Smart Diagnostic System for Health Risk Assessment
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- DERMATOLOGICAL COMPOSITION OF DEODORANTS AND POTENTIAL CUTANEOUS RISKS: A NARRATIVE REVIEW AND CLINICAL IMPLICATIONS
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations